It is currently available only within clinical trials, and any use outside a trial setting would be considered off-label and is not recommended
In 2025, the default explanation seems to be Ozempic. I track my cardiovascular age to ensure my workouts improve my health and not just my appearance
PCI: percutaneous coronary intervention Optimising glucose control during hospital admissions for ACS and elective PCI AGGRESSIVE VERSUS NON-AGGRESSIVE GLUCOSE LOWERING The benefits of an accurate glycaemic control in patients with diabetes and ACS was first demonstrated by the results of the DIGAMI trial, which showed that a more aggressive, insulin-based approach, compared with conventional treatment of hyperglycaemia at hospital admission and maintained long term, was associated with a significant reduction of mortality at 1, 3, and 5 years31
Mechanistically, it upregulates VEGFR2 signalling, stimulates angiogenesis and fibroblast proliferation, and modulates the inflammatory cytokine response [3]
Cytokine storm
